NUTEX HEALTH ANNOUNCES 1 FOR 15 REVERSE STOCK SPLIT From Investing.com

HOUSTON, April 5, 2024 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), today announced a 1-for-15 stock split of its common stock effective as of market open on Tuesday 10 April 2024.

The share split will have legal effect starting from 11:59pm Eastern Time ON April 9, 2024and the Company’s common stock will be opened for trading on the Nasdaq Capital Market on April 10, 2024 on a post-split basis, under the existing stock symbol “NUTX” but with the new CUSIP number 67079U207. The stock split is part of the Company’s plan to restore compliance with the minimum offering price requirement for continued listing on the Nasdaq Capital Market.

The grouping was authorized by the Company’s Shareholders’ Meeting on June 29, 2023, giving the Company’s Board of Directors (the “Board”) the discretion to determine the timing and ratio of the split within a range of 1-2 and 1-15. The Board has now decided on the 1 in 15 ratio and will amend the Company’s amended and restated articles of incorporation to reflect this change.

Following the stock split, every fifteen shares of the Company’s common stock issued and outstanding prior to the start of trading April 10, 2024 will be consolidated into a single issued and outstanding share, with no change in par value per share of $0.001. No fractional shares will be issued as a result of the stock split. Shareholders of record who would otherwise be entitled to receive a fractional share will be entitled to have their fractional share rounded to the nearest whole number.

As a result of the stock split, the number of shares of common stock outstanding will be reduced from approximately 745 million shares to approximately 50 million shares, and the number of shares of common stock authorized will remain at 950 million shares. Additionally, the number of shares reserved for issuance under the Company’s equity compensation plan immediately prior to the stock split will be reduced proportionately. Changes will also be made to the Company’s outstanding warrants and stock options. The number of shares into which such securities are convertible or exercisable will be adjusted in line with the reverse split, as will the exercise prices of such securities.

From Nutex Health Inc.

Based in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a physician-led, technology-enabled integrated health care system comprised of 21 state-of-the-art micro hospitals in eight states and primary care-focused, risk-bearing physician networks with two divisions: a hospital Division ea Population Health Management Division.

The Hospital Division owns, develops and operates innovative healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in nine states.

The Population Health Management division owns and manages provider networks such as independent physician associations (IPAs). Through our Organization of management services (MSO), we provide management, administrative and other services to our affiliated hospitals and physician groups. Our proprietary cloud-based technology platform aggregates clinical and claims data from multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to provide higher quality care more efficiently.

Forward-Looking Statements

Certain statements and information included in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will,” “will likely be,” “expected,” ” continue,” “anticipate,” “estimated,” “expected,” “intend,” “target” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain known and unknown risks and uncertainties, many of which are beyond the Company’s control. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including final and interim rules implemented under the No Surprises Act, economic conditions, dependence on management, shareholder dilution, lack of capital, effects of rapid growth on the Company and management’s ability to respond effectively to growth and demand for the Company’s products and services, new technologies developing, the Company’s ability to compete, conflicts of interest in related business transactions between parties, regulatory issues, protection of technology, lack of industry standards, effects of competition and the Company’s ability to obtain future financing. An extensive list of factors that may affect future results is discussed in our Annual Report on Form 10-K for the year ended December 31, 2023 under the heading “Risk Factors” in Part I, point IA, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could adversely affect the Company’s financial performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed in this press release.